Medilab24
Reader Perspectives on Primary Care Value and Obesity Classification

Reader Perspectives on Primary Care Value and Obesity Classification

Hemoglobin A1c, also known as HbA1c or glycated hemoglobin, is a laboratory test that measures the average blood sugar levels over the past two to three months. This test is essential for diagnosing and monitoring diabetes. When glucose in the bloodstream binds to hemoglobin in red blood cells, it forms glycated hemoglobin. Since red blood cells live for approximately three months, the HbA1c test provides a longer-term picture of blood sugar control compared to daily glucose measurements.

The HbA1c test is performed through a simple blood sample that can be taken at any time of day, without requiring fasting. Normal HbA1c levels are below 5.7 percent. A result between 5.7 and 6.4 percent indicates prediabetes, which means blood sugar levels are higher than normal but not yet high enough to be classified as diabetes. An HbA1c level of 6.5 percent or higher on two separate tests indicates diabetes. For people already diagnosed with diabetes, the target HbA1c level is typically below 7 percent, though individual goals may vary based on age, health status, and other factors.

Healthcare providers use the HbA1c test for multiple purposes. It helps diagnose type 2 diabetes and prediabetes, monitors how well diabetes treatment plans are working, and assists in making decisions about medication adjustments. Unlike daily blood glucose tests that show blood sugar at a single moment, HbA1c reflects overall glucose control over weeks and months. This makes it valuable for assessing the effectiveness of diabetes management strategies including diet, exercise, and medications.

The frequency of HbA1c testing depends on individual circumstances. People with diabetes who are meeting treatment goals and have stable blood sugar levels typically need testing twice a year. Those who have changed their treatment plan or are not meeting their goals may need testing more frequently, possibly every three months. People diagnosed with prediabetes should have the test at least once a year to monitor their condition. Certain factors can affect test accuracy, including recent blood transfusions, certain types of anemia, kidney or liver disease, and some genetic variations in hemoglobin. If you have any of these conditions, your healthcare provider may recommend alternative testing methods or interpret results differently.